NARDONE, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 314
EU - Europa 292
AS - Asia 171
SA - Sud America 17
AF - Africa 3
Totale 797
Nazione #
US - Stati Uniti d'America 307
RU - Federazione Russa 88
PL - Polonia 83
SG - Singapore 48
CN - Cina 42
HK - Hong Kong 28
IE - Irlanda 24
IT - Italia 19
SE - Svezia 19
DE - Germania 16
IN - India 16
KR - Corea 15
BR - Brasile 13
GB - Regno Unito 13
FI - Finlandia 10
FR - Francia 8
VN - Vietnam 7
CA - Canada 6
UA - Ucraina 6
JO - Giordania 5
ID - Indonesia 4
AR - Argentina 2
CZ - Repubblica Ceca 2
MA - Marocco 2
PK - Pakistan 2
SA - Arabia Saudita 2
CI - Costa d'Avorio 1
CL - Cile 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
NL - Olanda 1
PT - Portogallo 1
VE - Venezuela 1
Totale 797
Città #
Santa Clara 96
Warsaw 83
Ashburn 49
Singapore 41
Hong Kong 26
Dublin 24
Fairfield 20
Seoul 15
Hefei 13
Houston 12
Chandler 11
Mumbai 9
Munich 9
Altamura 8
Beijing 8
Florence 8
Lawrence 8
Woodbridge 8
Wilmington 7
Cambridge 6
Dearborn 6
Dong Ket 6
Helsinki 6
San Jose 5
Seattle 5
Buffalo 4
Jakarta 4
Montreal 4
Paris 4
Princeton 4
Turku 4
Clifton 3
Kent 3
Los Angeles 3
Moscow 3
Norwalk 3
San Diego 3
Boston 2
Council Bluffs 2
Guangzhou 2
Hillsboro 2
London 2
Medford 2
Nanjing 2
Abidjan 1
Angra dos Reis 1
Aparecida do Taboado 1
Athens 1
Bengaluru 1
Brasília 1
Brno 1
Buenos Aires 1
Canoas 1
Carney 1
Ceará Mirim 1
Chicago 1
Columbus 1
Concepción 1
Córdoba 1
Dallas 1
Denver 1
Diamantina 1
Fes 1
Garanhuns 1
Guarulhos 1
Gujranwala 1
Gurupi 1
Helena 1
Ho Chi Minh City 1
Jacksonville 1
Jeddah 1
Kaunas 1
Kilburn 1
Lahore 1
Laurel 1
Limeira 1
Los Teques 1
Lucas do Rio Verde 1
Medina 1
Meknes 1
New York 1
Newark 1
Nottingham 1
Olomouc 1
Pune 1
Quanzhou 1
Querétaro 1
Redondo Beach 1
Romola 1
San Francisco 1
Shanghai 1
Sinop 1
São Paulo 1
Tokyo 1
Toronto 1
Wandsworth 1
Washington 1
Totale 598
Nome #
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 238
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 232
The microbial safety of edible insects: A matter of processing 170
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 166
Totale 806
Categoria #
all - tutte 2.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 6 9 13 24 2 6
2021/202236 3 1 0 3 0 3 3 3 0 3 4 13
2022/202373 7 22 6 1 3 12 14 1 7 0 0 0
2023/202432 0 5 4 0 3 9 2 5 0 0 3 1
2024/2025284 15 24 16 43 70 45 4 18 6 8 10 25
2025/2026184 40 35 28 25 37 8 11 0 0 0 0 0
Totale 806